Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.85% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 12.37% |
| 4 | Industrials | 10.61% |
| 5 | Consumer Staples | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IRC
1451
DELISTED
INLAND REAL ESTATE CORP
IRC
| $3.4M | 0.01% |
319,900
+68,900
| +27% | +$725K |
|
|
RNWK
1452
DELISTED
RealNetworks Inc
RNWK
| $3.4M | 0.01% |
445,423
+42,100
| +10% | +$318K |
|
1453
Darling Ingredients
DAR
$10.5B
| $3.38M | 0.01% |
161,600
+17,036
| +12% | +$344K |
|
1454
First Citizens BancShares
FCNCA
$25.8B
| $3.38M | 0.01% |
13,784
-6,773
| -33% | -$1.58M |
|
1455
American Coastal Insurance
ACIC
$467M
| $3.38M | 0.01% |
195,600
+153,300
| +362% | +$2.5M |
|
1456
Harvard Bioscience
HBIO
$30.3M
| $3.37M | 0.01% |
74,040
+15,583
| +27% | +$655K |
|
1457
Hecla Mining
HL
$12.5B
| $3.37M | 0.01% |
+976,265
| New | +$3M |
|
1458
Village Super Market
VLGEA
$634M
| $3.35M | 0.01% |
142,000
+8,021
| +6% | +$194K |
|
|
USCR
1459
DELISTED
U S Concrete, Inc.
USCR
| $3.34M | 0.01% |
135,069
-54,731
| -29% | -$1.33M |
|
1460
Core Molding Technologies
CMT
$227M
| $3.33M | 0.01% |
255,800
+5,800
| +2% | +$71.9K |
|
|
CBST
1461
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $3.31M | 0.01% |
47,420
-141,671
| -75% | -$9.64M |
|
|
TGB
1462
Trekor Metals
TGB
$3.1B
| $3.3M | 0.01% |
1,322,500
+555,000
| +72% | +$1.2M |
|
|
MFI
1463
DELISTED
MICROFINANCIAL INC
MFI
| $3.3M | 0.01% |
427,400
+8,400
| +2% | +$66K |
|
|
MITT
1464
TPG Mortgage Investment Trust
MITT
$215M
| $3.3M | 0.01% |
58,071
-98,542
| -63% | -$5.43M |
|
|
OVTI
1465
DELISTED
OMNIVISION TECHNOLOGIES INC
OVTI
| $3.3M | 0.01% |
+150,040
| New | +$3.06M |
|
1466
Adeia
ADEA
$3.32B
| $3.29M | 0.01% |
562,895
+346,301
| +160% | +$2.04M |
|
|
BEBE
1467
DELISTED
Bebe Stores Inc
BEBE
| $3.28M | 0.01% |
107,631
+103,011
| +2,230% | +$4.77M |
|
|
HI
1468
DELISTED
Hillenbrand
HI
| $3.27M | 0.01% |
100,300
-99,673
| -50% | -$3.08M |
|
1469
Stryker
SYK
$130B
| $3.27M | 0.01% |
+38,800
| New | +$3.17M |
|
|
EQY
1470
DELISTED
Equity One
EQY
| $3.27M | 0.01% |
138,600
+31,433
| +29% | +$715K |
|
|
VRE
1471
DELISTED
Veris Residential
VRE
| $3.27M | 0.01% |
152,100
-684,485
| -82% | -$14.5M |
|
|
EVOL
1472
DELISTED
Evolving Systems, Inc.
EVOL
| $3.26M | 0.01% |
381,172
+20,473
| +6% | +$171K |
|
|
FDML
1473
DELISTED
Federal-Mogul Holdings Corporation
FDML
| $3.26M | 0.01% |
161,100
-234,700
| -59% | -$4.2M |
|
|
RIC
1474
DELISTED
Richmont Mines Inc.
RIC
| $3.25M | 0.01% |
2,372,500
-17,800
| -0.7% | -$23.2K |
|
|
GG
1475
DELISTED
Goldcorp Inc
GG
| $3.25M | 0.01% |
+116,351
| New | +$2.89M |
|
Similar funds
Jim Simons's Q2 2014 Portfolio in Review
As of Q2 2014, Jim Simons held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Jim Simons added most to Pfizer in Q2 2014, an estimated $276M increase.
- Jim Simons's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Jim Simons fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Jim Simons's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Jim Simons opened 450 new positions and closed 492 in Q2 2014.
- Jim Simons's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.